Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Cash from Operations (2016 - 2025)

Historic Cash from Operations for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $49000.0.

  • International Stem Cell's Cash from Operations fell 8093.39% to $49000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$98000.0, marking a year-over-year decrease of 13951.61%. This contributed to the annual value of $13000.0 for FY2024, which is 9860.06% down from last year.
  • According to the latest figures from Q3 2025, International Stem Cell's Cash from Operations is $49000.0, which was down 8093.39% from -$300000.0 recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's Cash from Operations ranged from a high of $490000.0 in Q2 2023 and a low of -$394000.0 during Q1 2021
  • In the last 5 years, International Stem Cell's Cash from Operations had a median value of $49000.0 in 2025 and averaged -$2473.7.
  • As far as peak fluctuations go, International Stem Cell's Cash from Operations tumbled by 191666.67% in 2021, and later skyrocketed by 103913.04% in 2023.
  • Quarter analysis of 5 years shows International Stem Cell's Cash from Operations stood at -$316000.0 in 2021, then soared by 125.0% to $79000.0 in 2022, then soared by 103.8% to $161000.0 in 2023, then crashed by 145.96% to -$74000.0 in 2024, then skyrocketed by 166.22% to $49000.0 in 2025.
  • Its Cash from Operations was $49000.0 in Q3 2025, compared to -$300000.0 in Q2 2025 and $227000.0 in Q1 2025.